Skip to content

AbCellera Biologics Inc. ABCL Change in Income Taxes

Change in Income Taxes at other companies

Zymeworks logo
ZymeworksZYME
-$16K-1,500%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$187M+246%
Roivant Sciences logo
Roivant SciencesROIV
$21.26M+946%

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%
Enterprise value$1.88B+100.0%
P/S23.3×-26.8×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s change in income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s change in income taxes?
AbCellera Biologics Inc. (ABCL) reported change in income taxes of -$4.97M in Q1 2026.
How has AbCellera Biologics Inc.'s change in income taxes changed year-over-year?
AbCellera Biologics Inc.'s change in income taxes decreased by 12.7% year-over-year, from -$4.41M to -$4.97M.
What is the long-term trend for AbCellera Biologics Inc.'s change in income taxes?
Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s change in income taxes has grown at a -30.4% compound annual growth rate (CAGR), from -$88.61M to -$29.84M.
What does change in income taxes mean?
Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.